News
13hon MSN
Experts are raising concerns about Benadryl’s ability to cross the blood-brain barrier and potential lasting impacts.
14hon MSN
New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD). In preclinical DMD mouse models, investigators demonstrated ...
New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD). In ...
1h
News-Medical.Net on MSNTargeting GLUD1 shows promise in restoring muscle function in Duchenne muscular dystrophyNew research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD). In preclinical DMD mouse models, investigators demonstrated ...
Salvia rosmarinus, the fragrant plant also known as rosemary, has a unique and delicious flavor and is useful in many ...
13h
Health on MSNShould You Stop Using Benadryl? Some Doctors Think SoA new paper argues that the popular allergy medication is a worse choice than newer drugs, like Claritin and Allegra. Experts explain why, and reveal whether you should switch your meds.
Three patient outcomes were measured in this new study: time to onset of ocular-related myasthenia gravis, Activities of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results